Grifols, S.A. reported €7.21B of revenue over the trailing twelve months, +9.4% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: €7.21B (to FY2024). Net income: €157M, trailing twelve months to FY2024. Free cash flow: €670M, trailing twelve months to FY2024. Operating margin: 17%, trailing twelve months to FY2024.

GRFSGrifols, S.A.

Healthcare

$7.45-24% 1Y

$7.45

$7.0052 weeks$10.02

GRFS as reported

Grifols, S.A. reported €7.21B of revenue over the trailing twelve months, +9.4% on the year before. 10 reported series are charted on this page, each one as filed.

€7.21B

Revenue, trailing twelve months · to FY2024 · +9.4% against the twelve months before

Net income: €157M
Net income · +271% year on year · trailing twelve months to FY2024
Free cash flow: €670M
Free cash flow · −11750% year on year · trailing twelve months to FY2024
Operating margin: 17%
Operating margin · trailing twelve months to FY2024

Details›

Every series Ryufin has for GRFS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	€7.21B	+9.4%	FY2024
Net income	€157M	+271%	FY2024
EPS	€0.23	+283%	FY2024
Gross margin	39%	n/a	FY2024
Operating margin	17%	n/a	FY2024
Net margin	2.2%	n/a	FY2024
ROE	2.7%	n/a	FY2024
ROA	0.73%	n/a	FY2024
ROIC	12%	n/a	FY2024
Free cash flow	€670M	−11750%	FY2024

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.